Corbus Pharmaceuticals Holdings (CRBP) Interest Expenses (2013 - 2024)
Corbus Pharmaceuticals Holdings (CRBP) recorded quarterly Interest Expenses of $381000.0 in Q3 2024, down 41.56% quarter-over-quarter from $652000.0 in Q2 2024, and down 61.12% on a YoY basis from $980000.0 in Q4 2023.
Corbus Pharmaceuticals Holdings (CRBP) Interest Expenses (2013 - 2024) Analysis & Trends
Corbus Pharmaceuticals Holdings' Interest Expenses history runs 6 years deep, the most recent figure standing at $381000.0 for Q3 2024.
- In Q3 2024, Interest Expenses fell 61.12% year-over-year to $381000.0; the TTM figure through Jun 2025 stood at $381000.0 (down 88.8% YoY), while the FY2024 annual figure was $1.9 million, down 51.48% from the prior year.
- Interest Expenses was $381000.0 for Q3 2024 at Corbus Pharmaceuticals Holdings, down from $652000.0 in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $1.0 million in Q2 2023 to a low of $381000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 61,000.00 |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | -332,000.00 |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | - |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | -5.58 Mn |
| 10 | Corbus Pharmaceuticals Holdings | 136.49 Mn | 108.68 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 381,000.00 |
| Sep 30, 2024 | 381,000.00 |
| Jun 30, 2024 | 652,000.00 |
| Jun 30, 2024 | 652,000.00 |
| Mar 31, 2024 | 839,000.00 |
| Mar 31, 2024 | 839,000.00 |
| Dec 31, 2023 | 930,000.00 |
| Dec 31, 2023 | 930,000.00 |
| Sep 30, 2023 | 980,000.00 |
| Sep 30, 2023 | 980,000.00 |
| Jun 30, 2023 | 1.00 Mn |
| Jun 30, 2023 | 1.00 Mn |
| Mar 31, 2016 | 6,430.00 |
| Mar 31, 2016 | 6,430.00 |
| Dec 31, 2015 | 1,068.00 |
| Dec 31, 2015 | 1,068.00 |
| Jun 30, 2015 | 393.00 |
| Jun 30, 2015 | 393.00 |
| Mar 31, 2015 | 979.00 |
| Mar 31, 2015 | 979.00 |